|
Nasdaq Regeneron Pharmaceuticals Inc., up $12.57 at $114.65 The biopharmaceutical company expects sales of eye drug Eylea to reach $300 million, up from its previous forecast of $160 million. Fossil Inc., up $4.01 at $104.50 A Jefferies analyst kept his "Buy" rating on the watch maker saying that the company was a "big winner" over the holidays.
Copyright 2012 The Associated
Press. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
News | Sports | Business | Rural Review | Teaching & Learning | Home and Family | Tourism | Obituaries
Community |
Perspectives
|
Law & Courts |
Leisure Time
|
Spiritual Life |
Health & Fitness |
Teen Scene
Calendar
|
Letters to the Editor